Lung Cancer, An Issue of PET Clinics

<p>PET Clinics</p> <p>Lung Cancer </p> <p>Preface: Lung Cancer </p> <p>Staging of Non–Small-Cell Lung Cancer</p> <p>Lung Neoplasms with Low F18-Fluorodeoxyglucose Avidity </p> <SUP> <p>18</SUP>F-Fluoro-2-Deoxy-D-Glucose PET/Computed Tomography Evaluation of Lung Cancer in Populations with High Prevalence of Tuberculosis and Other Granulomatous Disease</p> <p>Genomic Characterization of Lung Cancer and Its Impact on the Use and Timing of</p> <p>PET in Therapeutic Response Assessment</p> <p>Treatment Planning for Radiation Therapy </p> <p>Prognostic Value of <SUP>18</SUP>F-Fluorodeoxyglucose PET/Computed Tomography in</p> <p>Non–Small-Cell Lung Cancer </p> <p>Non–Small-Cell Lung Cancer PET Imaging Beyond F18 Fluorodeoxyglucose</p> <p>Future Directions in PET Imaging of Lung Cancer</p> <p>Improved Detection of Small Pulmonary Nodules Through Simultaneous MR/PET</p> <p>Imaging</p> <p>Practical Considerations for Clinical PET/MR Imaging</p> <p>Diagnostic Imaging and Newer Modalities for Thoracic Diseases: PET/Computed Tomographic Imaging and Endobronchial Ultrasound for Staging and Its Implication for Lung Cancer</p>